Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.

This publication has 9 references indexed in Scilit:

• Leuprolide versus Diethylstilbestrol for Metastatic Prostate Cancer
  New England Journal of Medicine, 1984
• Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor.
  Annals of the Rheumatic Diseases, 1984
• Use of monoclonal antibodies and F(ab′)2 enzyme conjugates in ELISA for IgM, IgA and IgG rheumatoid factors
  Journal of Immunological Methods, 1984
• The hand radiograph as a diagnostic discriminant between seropositive and seronegative ‘rheumatoid arthritis’: a controlled study.
  Annals of the Rheumatic Diseases, 1983
• Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer.
  BMJ, 1983
• New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens
  The Prostate, 1983
• SUSTAINED SUPPRESSION OF TESTOSTERONE PRODUCTION BY THE LUTEINISING-HORMONE RELEASING-HORMONE AGONIST BUSERELIN IN PATIENTS WITH ADVANCED PROSTATE CARCINOMA
  The Lancet, 1982
• Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.
  Proceedings of the National Academy of Sciences, 1982
• Prospective study of the early course of rheumatoid arthritis in young adults: Comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlating with outcome
  Seminars in Arthritis and Rheumatism, 1976